Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine + lamotrigine vs quetiapine monotherapy, and folic acid vs placebo in bipolar depression
2007-004513-33Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Mar 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of quetiapine, lamotrigine and folic acid in bipolar disorder (BD) (4 arms), sponsored by University of Oxford. Started Mar 2008; status: completed.
02
Drugs
quetiapinelamotriginefolic acid
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2007-004513-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004513-33.